Tucatinib early access
Hi all,
Given the benefit tucatinib demonstrated in patients with brain mets, I wanted to flag a trial protocol out of Seattle Genetics which is designed to provide tucatinib (possibly with trastuzumab + chemo) ahead of the anticipated FDA formal approval. https://clinicaltrials.gov/ct2/show/NCT04220203 Wishing a happy and healthy 2020 to everybody. |
All times are GMT -7. The time now is 09:07 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021